Abstract:Neuronal hyperexcitability is a key driver of persistent pain states including neuropathic pain. Leucine-rich, glioma inactivated 1 (LGI1), is a secreted protein known to regulate excitability within the nervous system and is the target of autoantibodies from neuropathic pain patients. Therapies that block or reduce antibody levels are effective at relieving pain in these patients, suggesting that LGI1 has an important role in clinical pain. Here we have investigated the role of LGI1 in regulating neuronal excitability and pain-related sensitivity by studying the consequences of genetic ablation in specific neuron populations using transgenic mouse models. LGI1 has been well studied at the level of the brain, but its actions in the spinal cord and peripheral nervous system (PNS) are poorly understood. We show that LGI1 is highly expressed in DRG and spinal cord dorsal horn neurons in both mouse and human. Using transgenic muse models, we genetically ablated LGI1, either specifically in nociceptors (LGI1 fl/Nav1.8+ ), or in both DRG and spinal neurons (LGI1 fl/Hoxb8+ ). On acute pain assays, we find that loss of LGI1 resulted in mild thermal and mechanical pain-related hypersensitivity when compared to littermate controls. In from LGI1 fl/Hoxb8+ mice, we find loss of Kv1 currents and hyperexcitability of DRG neurons. LGI1 fl/Hoxb8+ mice displayed a significant increase in nocifensive behaviours in the second phase of the formalin test (not observed in LGI1 fl/Nav1.8+ mice) and extracellular recordings in LGI1 fl/Hoxb8+ mice revealed hyperexcitability in spinal dorsal horn neurons, including enhanced wind-up. Using the spared nerve injury model, we find that LGI1 expression is dysregulated in the spinal cord. LGI1 fl/Nav1.8+ mice showed no differences in nerve injury induced mechanical hypersensitivity, brush-evoked allodynia or spontaneous pain behaviour compared to controls. However, LGI1 fl/Hoxb8+ mice showed a significant exacerbation of mechanical hypersensitivity and allodynia. Our findings point to effects of LGI1 at both the level of the DRG and spinal cord, including an important impact of spinal LGI1 on pathological pain. Overall, we find a novel role for LGI1 with relevance to clinical pain.

The Roles of Leucine Enriched Protein LGI1 in the Occurrence of Epilepsy

The LGI1 protein: molecular structure, physiological functions and disruption-related seizures

Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination Via TSC-mTOR Signaling

A Patient-Derived Mutation of Epilepsy-Linked LGI1 Increases Seizure Susceptibility Through Regulating Kv1.1.

LGI1 is Involved in the Development of Mouse Brain

Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures

An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel

Progression of brain tumor and members of leucine-rich repeat superfamily

Familial mesial temporal lobe epilepsy phenotype is associated with novel LGI1 variants: A report of two families

14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice

Lgi1 Null Mutant Mice Exhibit Myoclonic Seizures and Ca1 Neuronal Hyperexcitability

A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity

The Role of Exercise in Modulating the HP Pathway to Reduce Glioma-Induced Epilepsy

The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons

Clinical and imaging features of leucine-rich glioma inactivated 1 antibody associated autoimmune encephalitis

A novel <i>Lgi1</i> mutation causes white matter abnormalities and impairs motor coordination in mice

G‐alpha Interacting Protein Interacting Protein, C Terminus 1 Regulates Epileptogenesis by Increasing the Expression of Metabotropic Glutamate Receptor 7

Celecoxib Ameliorates Seizure Susceptibility in Autosomal Dominant Lateral Temporal Epilepsy.

Autosomal dominant lateral temporal epilepsy in a family exhibiting a rare heterozygous mutation and deletion in the leucine-rich glioma inactivated 1 gene

Expression Studies in Gliomas and Glial Cells Do Not Support a Tumor Suppressor Role for LGI11